• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-018
Device Problem Difficult to Remove (1528)
Patient Problem Embolism (1829)
Event Date 03/17/2014
Event Type  Injury  
Event Description
The patient's secundum atrial septal defect measured 13.5mm in diameter with a total septal length of 45mm.The stop-flow stretch diameter by echocardiogram and cine was 19-20mm in diameter.Initially, the atrial septal defect was closed using an 18mm amplatzer septal occluder (aso) after the push-pull technique demonstrated device stability; however, upon release the aso embolized into the left atrium and then into the left ventricle.The aso could not be retrieved through the 10f so it was exchanged for a 12f sheath which was used to successfully remove the device.The septal defect was found to be larger than previously anticipated and a 30mm aso was implanted successfully.
 
Manufacturer Narrative
The 18mm aso was returned to sjm and decontaminated.The aso was grossly and microscopically examined, and no anomalies were found.The device history record for this product was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.The results of this investigation confirmed the amplatzer septal occluder met all functional and dimensional specifications when analyzed at sjm.There was no evidence to suggest there was an intrinsic defect in the occluder, and the cause for the embolization remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key3730940
MDR Text Key4329860
Report Number2135147-2014-00028
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/18/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/07/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date06/20/2017
Device Model Number9-ASD-018
Device Lot Number1207136114
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/01/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/18/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/20/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age7 MO
-
-